133 related articles for article (PubMed ID: 1979645)
1. Effects of the antisense v-myb' expression on K562 human leukemia cell proliferation and differentiation.
Kamano H; Ohnishi H; Tanaka T; Ikeda K; Okabe A; Irino S
Leuk Res; 1990; 14(10):831-9. PubMed ID: 1979645
[TBL] [Abstract][Full Text] [Related]
2. Antisense src expression inhibits U937 human leukemia cell proliferation in conjunction with reduction of c-myb expression.
Waki M; Kitanaka A; Kamano H; Tanaka T; Kubota Y; Ohnishi H; Takahara J; Irino S
Biochem Biophys Res Commun; 1994 Jun; 201(2):1001-7. PubMed ID: 7516155
[TBL] [Abstract][Full Text] [Related]
3. p75c-myb expression in leukemia-lymphoma cells correlated with proliferation and differentiation.
Ohnishi H; Kamano H; Tanaka T; Okabe A; Irino S
Leuk Res; 1990; 14(5):423-32. PubMed ID: 2189045
[TBL] [Abstract][Full Text] [Related]
4. Effects of the antisense myb expression on hemin- and erythropoietin-induced erythroid differentiation of K562 cells.
Kamano H; Tanaka T; Ohnishi H; Kubota Y; Ikeda K; Takahara J; Irino S; Ottalenghi S
Biochem Mol Biol Int; 1994 Aug; 34(1):85-92. PubMed ID: 7849628
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of in vitro proliferation of chronic myelogenous leukemia progenitor cells by c-myb antisense oligodeoxynucleotides.
Szczylik C; Skórski T; Malaguarnera L; Hetman J; Chen ST; Calabretta B
Folia Histochem Cytobiol; 1996; 34(3-4):129-34. PubMed ID: 8967957
[TBL] [Abstract][Full Text] [Related]
6. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides.
Ratajczak MZ; Kant JA; Luger SM; Hijiya N; Zhang J; Zon G; Gewirtz AM
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11823-7. PubMed ID: 1281545
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional activation of the miR-17-92 cluster is involved in the growth-promoting effects of MYB in human Ph-positive leukemia cells.
Spagnuolo M; Regazzo G; De Dominici M; Sacconi A; Pelosi A; Korita E; Marchesi F; Pisani F; Magenta A; Lulli V; Cordone I; Mengarelli A; Strano S; Blandino G; Rizzo MG; Calabretta B
Haematologica; 2019 Jan; 104(1):82-92. PubMed ID: 30076175
[TBL] [Abstract][Full Text] [Related]
8. Induced dendritic cell differentiation of chronic myeloid leukemia blasts is associated with down-regulation of BCR-ABL.
Lindner I; Kharfan-Dabaja MA; Ayala E; Kolonias D; Carlson LM; Beazer-Barclay Y; Scherf U; Hnatyszyn JH; Lee KP
J Immunol; 2003 Aug; 171(4):1780-91. PubMed ID: 12902478
[TBL] [Abstract][Full Text] [Related]
9. Dissociation between p93B-myb and p75c-myb expression during the proliferation and differentiation of human myeloid cell lines.
Arsura M; Luchetti MM; Erba E; Golay J; Rambaldi A; Introna M
Blood; 1994 Apr; 83(7):1778-90. PubMed ID: 8142646
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells.
Soliera AR; Lidonnici MR; Ferrari-Amorotti G; Prisco M; Zhang Y; Martinez RV; Donato NJ; Calabretta B
Blood; 2008 Sep; 112(5):1942-50. PubMed ID: 18550858
[TBL] [Abstract][Full Text] [Related]
11. c-myc and c-myb oncoproteins during induced maturation of myeloid and erythroid human leukemic cell lines.
Pedrazzoli P; Bains MA; Watson R; Fisher J; Hoy TG; Jacobs A
Cancer Res; 1989 Dec; 49(24 Pt 1):6911-6. PubMed ID: 2684403
[TBL] [Abstract][Full Text] [Related]
12. Potential therapeutic applications of antisense oligodeoxynucleotides in the treatment of chronic myelogenous leukemia.
Gewirtz AM
Leuk Lymphoma; 1993; 11 Suppl 1():131-7. PubMed ID: 7504543
[TBL] [Abstract][Full Text] [Related]
13. EVI1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemia.
Ohyashiki K; Ohyashiki JH; Fujieda H; Shimamoto T; Kawakubo K; Nakazawa S; Suzukawa K; Morishita K; Toyama K
Leukemia; 1994 Dec; 8(12):2169-73. PubMed ID: 7808006
[TBL] [Abstract][Full Text] [Related]
14. A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines.
Algar EM; Khromykh T; Smith SI; Blackburn DM; Bryson GJ; Smith PJ
Oncogene; 1996 Mar; 12(5):1005-14. PubMed ID: 8649791
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
[TBL] [Abstract][Full Text] [Related]
16. Effect of differentiation-inducing agents on oncogene expression in a chronic myelogenous leukemia cell line.
Eisbruch A; Blick M; Evinger-Hodges MJ; Beran M; Andersson B; Gutterman JU; Kurzrock R
Cancer; 1988 Sep; 62(6):1171-8. PubMed ID: 3044574
[TBL] [Abstract][Full Text] [Related]
17. Interferon induces up-regulation of Spi-1/PU.1 in human leukemia K562 cells.
Gutiérrez P; Delgado MD; Richard C; Moreau-Gachelin F; León J
Biochem Biophys Res Commun; 1997 Nov; 240(3):862-8. PubMed ID: 9398659
[TBL] [Abstract][Full Text] [Related]
18. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
Anfossi G; Gewirtz AM; Calabretta B
Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic myelogenous leukemia (CML) with c-myb antisense oligodeoxynucleotides.
Gewirtz AM
Bone Marrow Transplant; 1994; 14 Suppl 3():S57-61. PubMed ID: 7697011
[No Abstract] [Full Text] [Related]
20. Multigene targeting with antisense oligodeoxynucleotides: an exploratory study using primary human leukemia cells.
Opalinska JB; Machalinski B; Ratajczak J; Ratajczak MZ; Gewirtz AM
Clin Cancer Res; 2005 Jul; 11(13):4948-54. PubMed ID: 16000594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]